Research that is free to access for all investors. Companies commission these providers to write research about them.
Brokers who write research on their corporate clients and make it available through our main bundle offering.
Research that is paid for directly by asset managers. Only accessible to institutional investors permissioned for access.
Event in Progress:
ImmuPharma plc (IMM:LON) | 11.8 0 3.5% | Mkt Cap: 59.1m
Dr Mike Mitchell | Andrew Blain
3 pages
Companies: ImmuPharma plc
Companies: XARZYTMEGPVCTIQEWMHIMMSFRCVSGPURPBURENTPTEC
Companies: IMM ORR SDI KRM CREO AREC DNM CORA AURR TTA
